首页> 外文期刊>Journal of Translational Medicine >Next-generation sequencing for diagnosis of thoracic aortic aneurysms and dissections: diagnostic yield, novel mutations and genotype phenotype correlations
【24h】

Next-generation sequencing for diagnosis of thoracic aortic aneurysms and dissections: diagnostic yield, novel mutations and genotype phenotype correlations

机译:新一代测序技术用于胸主动脉瘤和夹层的诊断:诊断率,新突变和基因型表型的相关性

获取原文
           

摘要

Background Thoracic aortic aneurysms and dissections (TAAD) are silent but possibly lethal condition with up to 40?% of cases being hereditary. Genetic background is heterogeneous. Recently next-generation sequencing enabled efficient and cost-effective examination of gene panels. Aim of the study was to define the diagnostic yield of NGS in the 51 TAAD patients and to look for genotype–phenotype correlations within families of the patients with TAAD. Methods 51 unrelated TAAD patients were examined by either whole exome sequencing or TruSight One sequencing panel. We analyzed rare variants in 10 established thoracic aortic aneurysms-associated genes. Whenever possible, we looked for co-segregation in the families. Kaplan–Meier survival curve was constructed to compare the event-free survival depending on genotype. Aortic events were defined as acute aortic dissection or first planned aortic surgery. Results and discussion In 21 TAAD patients we found 22 rare variants, 6 (27.3?%) of these were previously reported, and 16 (73.7?%) were novel. Based on segregation data, functional analysis and software estimations we assumed that three of novel variants were causative, nine likely causative. Remaining four were classified as of unknown significance (2) and likely benign (2). In all, 9 (17.6?%) of 51 probands had a positive result when considering variants classified as causative only and 18 (35.3?%) if likely causative were also included. Genotype-positive probands (n?=?18) showed shorter mean event free survival (41?years, CI 35–46) than reference group, i.e. those (n?=?29) without any plausible variant identified (51?years, CI 45–57, p?=?0.0083). This effect was also found when the ‘genotype-positive’ group was restricted to probands with ‘likely causative’ variants (p?=?0.0092) which further supports pathogenicity of these variants. The mean event free survival was particularly low (37?years, CI 27–47) among the probands with defects in the TGF beta signaling (p?=?0.0033 vs. the reference group). Conclusions This study broadens the spectrum of genetic background of thoracic aneurysms and dissections and supports its potential role as a prognostic factor in the patients with the disease.
机译:背景胸主动脉瘤和夹层(TAAD)是无声的,但可能是致命的,有高达40%的病例是遗传性的。遗传背景是异质的。最近,新一代测序技术使基因面板的检测更加经济高效。该研究的目的是确定51例TAAD患者的NGS诊断率,并寻找TAAD患者家庭中的基因型与表型相关性。方法通过全外显子组测序或TruSight One测序小组检查了51名无关的TAAD患者。我们分析了10个已建立的胸主动脉瘤相关基因的罕见变异。只要有可能,我们都在家庭中寻求共同隔离。绘制了Kaplan–Meier生存曲线,以比较无事件生存的基因型。主动脉事件定义为急性主动脉夹层或首次计划的主动脉手术。结果与讨论在21位TAAD患者中,我们发现了22种罕见变体,其中先前报道了6种(27.3%),而16种(73.7%)是新颖的。根据隔离数据,功能分析和软件估计,我们假设三种新变体是致病性的,九种可能是致病性的。其余四个分类为重要性不明(2)和可能是良性(2)。在考虑仅归类为致病性的变体时,总共51个先证者中有9个(17.6%)有阳性结果,如果包括可能的致病性,则有18个(35.3%)。基因型阳性先证者(n?=?18)的平均无事件生存期(41?years,CI 35–46)比参考组短,即那些未发现任何合理变异(51?years,51)的人(n?=?29)。 CI 45–57,p?=?0.0083)。当“基因型阳性”人群仅限于具有“可能致病性”变体的先证者(p?=?0.0092)时,也发现了这种效应,从而进一步支持了这些变体的致病性。在TGFβ信号缺陷的先证者中,无事件的平均生存期特别低(37岁,CI 27-47)(相对于参考组,p = 0.0033)。结论这项研究拓宽了胸动脉瘤和夹层的遗传背景,并支持了其作为该病患者预后因素的潜在作用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号